Canopy Growth vs. Aurora Cannabis: Which Is the Better Buy?
The Motley Fool
Published Jul 20, 2021 08:17
Updated Jul 20, 2021 08:45
Canopy Growth vs. Aurora Cannabis: Which Is the Better Buy?
Cannabis stocks were a growth machine for investors following the 2015 Canadian federal election. The hype for recreational legalization ramped up, and Liberal leaders Justin Trudeau managed to deliver on the promise. However, the reality of the rollout started to sour investors on the sector. As it stands today, the Canadian cannabis market is in desperate need of a boost to bring it back in the eyes of investors. Today, I want to look at Canopy Growth (TSX:WEED)(NYSE:CGC) and Aurora Cannabis (TSX:ACB)(NYSE:ACB), two top producers whose shares have plunged in 2021. Which is the better buy today? Let’s jump in.
The case for Canopy Growth this summer Canopy Growth is the largest cannabis producer listed on the TSX. Its shares have dropped 25% in 2021 as of close on July 19. The stock is still up 3.1% from the prior year.
Back in June, I’d discussed whether Canopy Growth would benefit from a potential legislative breakthrough in the United States on the cannabis question. On Wednesday, July 14, Democrats led by Senate Majority leader Chuck Schumer, Ron Wyden, and Cory Booker unveiled draft legislation to end the federal prohibition of cannabis . However, cannabis stocks still sold off, as the bill contains redistribution tax measures. Some speculate that this will prevent bipartisan support for the bill.
Canopy Growth released its fourth-quarter and full-year 2021 results on June 1. It achieved 37% revenue growth for the full year. The company has put itself on track to achieve positive adjusted EBITDA for the first time in the second half of fiscal 2022.
How does Aurora Cannabis look right now? Aurora is another huge cannabis producer in Canada. The company pursued an aggressive acquisition strategy immediately following recreational cannabis legalization. This spurred the stock to new heights, but it fought to live up to lofty expectations. Unlike Canopy Growth, Aurora failed to attract a major partnership like Constellation Brands (NYSE:STZ). Still, the company is also cheering on a potential breakthrough for federal legalization in the United States. In May 2020, Aurora announced its strategy to penetrate the U.S. market with the acquisition of a top CBD products company.
Shares of Aurora have also dropped 25% in the year-to-date period. Unlike Canopy Growth, the stock is down 42% from the prior year. Aurora has undergone stock splits and said goodbye to CEO Terry Booth in recent years. Is there reason for optimism going forward?
In Q3 2021, the company reported total cannabis net revenue before provisions of $58.4 million — down 19.5% from the prior year. However, its adjusted EBITDA loss did come in at $24 million — an improvement from a $49.6 million adjusted EBITDA loss in the third quarter of 2020.
Get The App
Which is the better buy? Aurora’s shareholders have been consistently punished in recent years. That has made it hard to trust this top cannabis stock for the long haul. The stock has been throttled since 2018 and 2019.
Canopy Growth’s stock has not fared better in 2021, but it has been more dependable overall. Moreover, the company is much better situated to enter the U.S. market. It is also on track to achieve positive adjusted EBITDA in its next fiscal year. I’m much more inclined to snatch up Canopy Growth stock in late July.
The post Canopy Growth vs. Aurora Cannabis: Which Is the Better Buy? appeared first on The Motley Fool Canada.
Fool contributor Ambrose O'Callaghan has no position in any stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.
This Article Was First Published on The Motley Fool
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.